Laser device for ophthalmology – ML6710i


Modulight's cloud-connected ophthalmic laser platform

ML6710i is a medical laser device for ophthalmology. ML6710i is designed for treatments in various ophthalmic indications. The laser is controlled intuitively from iPad app – the wireless connection allows flexibility for the treatment setup. A must-have tool for anyone in the field of ophthalmology. The laser beam is formed into a circular, adjustable and highly uniform spot by Modulight’s laser beam shaper.

Ophthalmologists operating Modulight’s ML6710i

Designed for Retina

Every part and feature within ML6710i is designed to fulfill one goal: Enabling safe and efficient ophthalmic treatments for patients and doctors. Read here why Bausch + Lomb chose Modulight as their exclusive laser provider.

The laser itself is packaged in an elegant and durable metallic case. The laser device is accompanied by an iPad, which is used for setting up the treatment and controlling the laser. The user interface has been optimized for easiness of use, while keeping up with the strict requirements of a medical laser.

ML6710i is connected to Modulight cloud, which enables safe storing of treatment logs, while not exposing patient data.

The laser light is formed into a uniform circular spot by Modulight laser beam shaper. The beam shaper can be attached into all common slit lamps.

ML6710i has the standard wavelength of 689 nm but according to customer wishes it can be built to include a different wavelength. When ordering, you may request a wavelength from UV to 2000+ nm – just ask Modulight sales team.

Modulight's cloud connected ophthalmic laser platform ML6710i

Modulight ML6710i Laser

  1. Laser main unit

  2. iPad with ML6710i App, wirelessly connected to the ML6710i laser and Modulight Cloud

  3. Foot switch for enabling laser emission

  4. Beam shaping unit

  5. Slit lamp

  6. Instrument table with height adjustment

Key features

  • The default built-in laser is 689 nm, 400 mW output power
  • Aiming beam (laser class 2) 635 nm
  • Possible to select any other Modulight laser in the wavelength  range of 400–2000 nm and power up to 3 W
  • Laser beam shaper easily attached to all common slit lamps
  • Treatment spot diameter adjustable to up to 14 mm diameter with 600 mW/cm2
  • Laser on/pause controlled by a foot switch
  • Key switch and interlock for laser safety


  • ML6710i is a modern ophthalmic laser which is very easy an intuitive to operate.
  • Thanks to the Modulight Cloud, all the operating parameters and laser on/off/pause events are safely stored into treatment log.
  • Setting the treatment parameters is very easy, thanks to the iPad app.
  • Laser on/pause can be controlled by a foot switch.

Technical specifications

Wavelength Laser output power Aiming beam Treatment spot size Irradiance
689 nm 400 mW 635 nm up to 14 mm 600 mW/cm2
class 3B class 2

Applications in ophthalmology

• Retinal PDT • Age-related macular degeneration AMD • Uveal melanoma • Ocular melanoma • Choroidal melanoma • Pathological myopia • Central serous retinopathy CSR • Polypoidal choroidal vasculopathy PCV •

Typical treatment flow for ML6710i

  1. Power up the laser device and log into the ML6710i application with your personal login credentials
  2. Configure desired treatment protocol settings. Settings that can be adjusted are displayed on blue.
  3. Select the preferred contact lens.
  4. Press start treatment and proceed to positioning contact lens.
  5. Start laser with foot switch.
  6. Treatment is completed after configured time and log is sent to Modulight cloud.

Laser connection status & my settings view

Modulight Cloud Analytics and Services

Modulight Cloud

  • User authentication to prevent unauthorized use
    • Personal user account and settings
  • Each treatment is recorded into the treatment history
    • Periodic summary report
  • Access to online guidebook and up-to-date training materials 24/7
  • Customer support to minimize the downtime (e.g. scheduling preventive maintenance)
  • Support chat integrated into the App for reaching tech support easily
  • Real-time device diagnostics for remote troubleshooting
  • Over-the-air software updates à faster access to new features

ML6710i case examples

Novel ophthalmic laser system paired with focal electroretinography for subthreshold laser therapy of DME

In the field of ophthalmic treatments, subthreshold laser therapy (SLT) has shown promise in addressing retinal diseases like diabetic macular edema (DME) and age-related macular degeneration (AMD). However, the precise control of therapeutic temperatures is challenging due to variations in individual eye characteristics. Modulight and Maculaser have addressed this issue with their innovative ML6710i device. This device utilizes a combination of laser beams to achieve precise thermal dosimetry-controlled retinal laser treatments. By monitoring focal electroretinography (fERG) from the target tissue, temperature-dependent changes are analyzed, ensuring accurate therapeutic temperatures for each patient. The device features an iOS-based graphical user interface (GUI), live fundus view, and data storage in the Modulight Cloud.

Novel ophthalmic PDT laser platform to target oncology and various other retinal indications

Laser systems, in ophthalmic applications, are utilized in the treatment of various ophthalmic diseases such as in ocular oncology and age-related macular degeneration through photochemical mechanism of photodynamic therapy. In addition, these lasers can be used to activate drug delivery systems in the retina to provide targeted drug therapy. PDT is a form of a combination treatment which utilizes light energy to activate a photoactive pharmaceutical (photosensitizer) to create a photodynamic reaction. Current photodynamic therapy devices out on the market are around 20 years old and the companies that manufacture the devices, do not provide yearly maintenance services for the devices. 

Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration (AMD) is one of the leading causes for  visual impairment. AMD is charactirized by development of Choroidal neovascularization (CNV) and consequent irreversible damage in the macula. CNV means abnormal development (angiogenesis) of blood vesseld from the choroid into Bruch’s membrane, sometimes capable of even perforating retinal pigment epithelium (RPE).

AMD is classified in two categories, dry and wet AMD.  The dry (atrophic) form of AMD is more common, but it may develop into wet AMD. Wet (exudative) AMD results in faster vision loss, and it is the leading cause for blindness in people over 65 years.

Request a Quotation or more information:

    First name *

    Family name *

    Company or affiliation *